Your session is about to expire
← Back to Search
Iyengar Yoga for Prolonged Grief Disorder (Yoga Trial)
N/A
Waitlist Available
Research Sponsored by Medical College of Wisconsin
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Male or female greater than or equal to 40 years of age
Presence of PGD
Must not have
Delirium/unstable medical conditions
Serious back, joint or neck injuries within the past 3 months
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 10 weeks
Awards & highlights
No Placebo-Only Group
Summary
This trial is testing if Iyengar Yoga can help older adults with prolonged grief disorder by changing how their brain and body handle emotions. The study will look at changes in the body and emotions after a period of yoga practice. Iyengar yoga has been shown to effectively reduce distress and improve psychological and physical outcomes in various populations.
Who is the study for?
This trial is for adults aged 40 or older who have been grieving for more than six months due to a loss and are diagnosed with Prolonged Grief Disorder (PGD). They must be able to see and hear well, score above 25 on the ICG grief scale, but can't join if they're at immediate risk of suicide, have certain neurological illnesses or severe psychiatric disorders, currently practice yoga, or have recent serious back injuries.
What is being tested?
The study is testing whether Iyengar Yoga (IY), a form of yoga known for its use of props and attention to detail in poses, can help people with PGD. Participants will either attend IY sessions or partake in social activities as a control group to compare effects on their mental health condition.
What are the potential side effects?
While not explicitly stated for this trial, typical side effects from practicing yoga might include muscle soreness or strain. The socialization control activity is unlikely to cause physical side effects but could potentially affect emotional state.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowSelect...
I am 40 years old or older.
Select...
I have been diagnosed with PGD.
Select...
I can see and hear well enough for daily activities.
Exclusion Criteria
You may be eligible for the trial if you check “No” for criteria below:Select...
I do not have delirium or unstable health conditions.
Select...
I have not had serious back, joint, or neck injuries in the last 3 months.
Select...
I have never had seizures, stroke, dementia, severe head injury, brain tumor or surgery.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ 10 weeks
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~10 weeks
Treatment Details
Study Objectives
Study objectives can provide a clearer picture of what you can expect from a treatment.Primary study objectives
Change in circulating endocannabinoid concentrations
Secondary study objectives
Change in neural activity measured using Functional magnetic resonance imaging (fMRI)
Inventory of Complicated Grief (ICG) scale score change
Awards & Highlights
No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.
Trial Design
3Treatment groups
Experimental Treatment
Active Control
Group I: Iyengar YogaExperimental Treatment1 Intervention
Participants will engage in 10 weekly IY classes
Group II: Socialization ControlActive Control1 Intervention
Participants will engage in 10 weekly socialization control group sessions
Group III: Healthy Comparison GroupActive Control1 Intervention
A group of participants will also be followed for 10 weeks
Research Highlights
Information in this section is not a recommendation. We encourage patients to speak with their healthcare team when evaluating any treatment decision.Mechanism Of Action
Side Effect Profile
Prior Approvals
Other Research
Common treatments for Prolonged Grief Disorder (PGD) often involve physical and mental exercises that aim to improve mental health and potentially alter neurobiological pathways. Techniques such as Iyengar Yoga, mindfulness meditation, and cognitive-behavioral therapy (CBT) work by promoting relaxation, reducing stress, and enhancing emotional regulation.
These practices help in modulating the body's stress response, improving mood, and fostering a sense of well-being. For PGD patients, these treatments are crucial as they address both the psychological and physiological aspects of grief, potentially leading to better mental health outcomes and improved quality of life.
Find a Location
Who is running the clinical trial?
Medical College of WisconsinLead Sponsor
628 Previous Clinical Trials
1,179,808 Total Patients Enrolled
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- I do not have delirium or unstable health conditions.You have experienced the loss of a loved one more than 6 months ago.You have had bipolar disorder or psychotic disorder, including psychotic depression, at any point in your life.I have not had serious back, joint, or neck injuries in the last 3 months.You have a current addiction or dependence on drugs or alcohol.You are currently doing yoga.I am 40 years old or older.You are currently experiencing thoughts of suicide.I have never had seizures, stroke, dementia, severe head injury, brain tumor or surgery.I have been diagnosed with PGD.You have a high score (more than 25) on a test that measures complicated grief.I can see and hear well enough for daily activities.
Research Study Groups:
This trial has the following groups:- Group 1: Iyengar Yoga
- Group 2: Socialization Control
- Group 3: Healthy Comparison Group
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Share this study with friends
Copy Link
Messenger